1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Basiliximab: new trials by email Literature Review of Basiliximab trials Research Report on Basiliximab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance Mesenchymal stem cells infusion, Basiliximab,Methylprednisolone,RATG ,Cyclosporine ,Mycophenolate mofetil, Basiliximab, Methylprednisolone,RATG,Cyclosporine,Mycophenolate mofetil - Kidney Transplant | Phase 1 / Phase 2 | Terminated | Mario Negri Institute for Pharmacological Research | 4 | 2008-05-01 | 2023-12-04 |
Mario Negri Institute for Pharmacological Research (1)
Italy (1)
Alessandro Rambaldi, MD (1) · Giuseppe Remuzzi, MD (1) · Marina Noris, CH Ph (1) · Martino Introna, MD (1) · Norberto Perico, MD (1)
PMID 20930086, PMID 23738760, PMID 29963053
2009 (1)